Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2026)
Biodexa Pharmaceuticals' Assets came in at $17.07 million for the quarter ended Jun 30, 2026, down 13.7% from $19.78 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals' Assets was $23.97 million, up 26.9% from the prior year.
- Assets has increased in each of the last three years, with a five-year compound annual growth rate of 13.7% (years ended Dec 2020 to Dec 2025).
- Going back by year, Assets was $18.89 million in the year ended Dec 31, 2024 (+44.1%), $13.11 million in the year ended Dec 31, 2023 (+91.8%), $6.84 million in the year ended Dec 31, 2022 (-61.5%) and $17.77 million in the year ended Dec 31, 2021 (+40.9%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Assets since the quarter ended Dec 31, 2023.
- Year-over-year, Assets increased in three of the last four quarters, with growth averaging 17.7%.
- The fastest year-over-year change in Assets over five years came in the quarter ended Dec 31, 2023 (growth of 101.9%), and the weakest in the quarter ended Dec 31, 2022 (a decline of 62.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Biodexa Pharmaceuticals | 4,123.69 | -23.40 Mn | - | 16.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.86 Mn |
| Dec 31, 2025 | 24.48 Mn |
| Jun 30, 2025 | 20.34 Mn |
| Dec 31, 2024 | 18.55 Mn |
| Jun 30, 2024 | 17.66 Mn |
| Dec 31, 2023 | 13.42 Mn |
| Jun 30, 2023 | 10.04 Mn |
| Dec 31, 2022 | 6.66 Mn |
| Dec 31, 2021 | 17.43 Mn |
| Jun 30, 2021 | 11.45 Mn |
| Dec 31, 2020 | 13.38 Mn |
| Jun 30, 2020 | 14.77 Mn |
| Dec 31, 2019 | 40.51 Mn |
| Jun 30, 2019 | 36.18 Mn |
| Dec 31, 2018 | 25.95 Mn |
| Jun 30, 2018 | 46.88 Mn |
| Dec 31, 2017 | 66.16 Mn |
| Jun 30, 2017 | 58.91 Mn |
| Dec 31, 2016 | 69.66 Mn |
| Jun 30, 2016 | 76.22 Mn |
API Access
Biodexa Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();